Morning Overview on MSN
A new drug may stop Alzheimer’s before memory loss starts
Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is ...
A Cherokee County man living with Sickle Cell Disease is now the first known person with the condition to get a medical pilot’s license.
An Illinois family pushed for both boys to receive the potentially life changing medical treatment after one was approved and ...
CRISPR Therapeutics (NASDAQ: CRSP) soared a few years ago, climbing more than 200% from the start of 2020 through early 2021, ...
Gene therapy has had its commercial struggles in the past year. The cost to patients is in the millions and fewer are stepping forward for treatment than companies would like. While development ...
A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...
Integrate current evidence-based interventions for MacTel into clinical practice to optimize disease outcomes. This activity ...
The past year has been marked by exceptional achievements – including our 50th anniversary – and inspiring moments, many ...
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...
It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...
Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results